A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL)
- Status
- COMPLETED
- Phase
- PHASE2
Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab
- Status
- COMPLETED
- Phase
- N/A
A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1
A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer
- Status
- COMPLETED
- Phase
- NA